Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tauriga Sciences Inc TAUG

Healthcare Biotechnology
Tauriga Sciences, Inc. is a science, technology and consumer products company. The Company operates through its subsidiary, Tauriga Pharma Corp., which is focused on the development of a pharmaceutical product line that is synergistic with the Company’s primary Cannabidiol (CBD) product line. The Company operates through two segments. The first division consists of all retail, wholesale and e-commerce product sales of CBD/CBG Tauri-Gum, Tauri-Gummies, and other CBD/CBG products. The second segment is the research and development division, which consists of liabilities and results from any activity relative to the progress in the development of the Company’s Food and Drug Administration (FDA) and Investigational New Drug (IND) application for Phase II Trial of its proposed pharmaceutical-grade version of Tauri-Gum. It also developed an immune booster version of Tauri-Gum chewing gum. This product contains 60 milligrams (mg) of Vitamin C and 10mg of Elemental Zinc per piece.


GREY:TAUG - Post by User

Tauriga Sciences Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(29)
•••
Post by AveragePennyon Jun 23, 2021 8:21am
96 Views
Post# 33433192

$TAUG Approved by Miami International Airport

$TAUG Approved by Miami International Airporthttps://www.globenewswire.com/news-release/2021/06/23/2251744/0/en/Tauriga-Sciences-Inc-s-Vendor-Registration-Approved-by-Miami-International-Airport-MIA.html

The Company is working closely with a South Florida based Airport Distribution firm, to sell its flagship Tauri-Gum™ product line to select U.S. based airports.  With the imminent commercial launch of its enhanced Tauri-Gum™ product line (9 SKUs), the Company is confident in its ability to compete for the business of air travelers.  Chewing gum products generate strong levels of sales within airport terminals (stores and kiosks).     
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities